Keyphrases
Ribavirin
100%
Chronic Hepatitis B
79%
COVID-19
72%
Plasma Concentration
62%
Pegylated Interferon
59%
Entecavir
49%
Chronic Hepatitis C
49%
Pharmacogenetics
44%
Hepatitis C Virus
43%
Hospitalized Patients
42%
Nave
42%
Telaprevir
39%
Sofosbuvir
39%
Genotype E
38%
Genotype
38%
Retrospective Analysis
37%
Peripheral Blood Mononuclear Cells
37%
High Performance Liquid Chromatography-tandem Mass Spectrometry (HPLC-MS/MS)
36%
MS Method
35%
Italy
34%
IL28B
34%
Vitamin D Pathway
34%
Virological Response
33%
Daclatasvir
30%
Sustained Virological Response
29%
Mixed Cryoglobulinemia
28%
Direct-acting Antivirals
25%
Pathway Genes
25%
Boceprevir
24%
Rs8099917
23%
Clinical Outcomes
23%
Hepatitis B Surface Antigen (HBsAg)
23%
SARS-CoV-2 Infection
23%
Polymorphism
23%
Triple Therapy
22%
HBeAg-negative
22%
Gene Polymorphism
22%
GS-331007
21%
Interferon-α (IFN-α)
21%
Peginterferon
21%
Rs12979860
21%
Tenofovir
21%
Interferon-free Therapy
20%
Multivariate Analysis
20%
Hepatitis B e Antigen (HBeAg)
19%
Hepatitis C Virus Genotypes
18%
SNP
18%
Plasma Parameters
17%
Genotype 1
17%
Clinical Characteristics
17%
Pharmacology, Toxicology and Pharmaceutical Science
Ribavirin
92%
Chronic Hepatitis B
79%
Hepatitis B Virus
77%
Peginterferon
57%
Infection
56%
Diseases
53%
Entecavir
49%
Chronic Hepatitis C
43%
Coronavirinae
42%
Telaprevir
39%
Pharmacogenetics
39%
Interferon
38%
Hepatitis B(e) Antigen
37%
Sofosbuvir
36%
Hepatitis B Antigen
35%
Vitamin D
34%
Daclatasvir
30%
Pharmacokinetics
29%
Hepatitis C Virus Genotype 1
26%
Hepatitis C Virus
26%
Boceprevir
24%
Antiviral Drug
22%
Tenofovir
21%
Fibrosis
18%
Hepatitis C
18%
Prospective Study
17%
Hepatitis B
17%
SARS Coronavirus
17%
Polyethylene Glycol
17%
Anemia
17%
Proteinase Inhibitor
17%
Cryoglobulinemia
17%
Syndrome
17%
Ritonavir
17%
Ombitasvir
17%
Paritaprevir
17%
Dasabuvir
17%
Liver Cirrhosis
16%
Hospital Mortality
16%
Prevalence
16%
Peginterferon Alpha
14%
Telbivudine
14%
Ultra High Performance Liquid Chromatography
13%
Adverse Event
12%
Virus DNA
12%
Tenofovir Disoproxil
12%
Adult Respiratory Distress Syndrome
11%
Simeprevir
11%
Remdesivir
11%
Liver Fibrosis
10%